H S R, Khobragade A, Satapathy D, Gupta M, et al. Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G
protein vaccine administered as simulated post exposure immunization: A
randomized, comparator controlled, multicenter, phase III clinical study. Hum Vaccin Immunother 2021 Sep 9:1-7. doi: 10.1080/21645515.2021.1957413.
PMID: 34499574